CORT compared with OMER: revenue, margins and what each company keeps, and the suppliers and customers both name

CORTCorcept Therapeutics Inc

Mkt capRevenueRevenue

OMEROmeros Corp

Mkt capRevenueRevenue

Compare

CORTCorcept Therapeutics Inc

OMEROmeros Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CORT 7

—Curant Health Georgiaunlistedsupplier

—Arcagy-Ginecounlistedsupplier

—Medpace Researchunlistedsupplier

—Optimeunlistedsupplier

3 more · CORT chain ›

Shared 0

No shared counterparties.

Only OMER 9

NVONovo Nordisk Healthcarecustomer

—Lonza Biologics Tuas Pteunlistedsupplier

—Vetter Pharma International, GmbHunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Novo Nordisk Healthcare

unlistedsupplier

5 more · OMER chain ›

CORTCorcept Therapeutics Inc

79.04▼−3.53%· post 79.50· delayed

Mkt cap$9.0BRevenue$340MQ3 FY26Revenue$761MFY25

OMEROmeros Corp

18.17▼−0.53%· post 18.03· delayed

After hoursNov 4 '26delayed

Mkt cap$1.3BRevenue$29MQ2 FY26Revenue—

Compare

After hoursNov 4 '26delayed

CORTCorcept Therapeutics Inc

OMEROmeros Corp

79.04▼−3.53%post 79.50delayed

Price

18.17▼−0.53%post 18.03delayed

$9.0B

Mkt cap

$1.3B

Q3 FY26$340M

Revenue

$29MQ2 FY26

FY25$761M

Revenue

—

CORT79.04▼−3.53%vsOMER18.17▼−0.53%After hoursNov 4 '26delayed